Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 42
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Hum Reprod ; 24(5): 1191-9, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19168871

RESUMO

BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) is a potentially life-threatening complication of ovarian stimulation associated with severe vascular hyperpermeability. Primary co-cultures of human luteinized granulosa cells (LGCs) and human umbilical vein endothelial cells (HUVECs) were used as a model of steroidgenic/endothelial cell interaction in OHSS. METHODS: hCG and the vascular endothelial growth factor (VEGF) inhibitor, Flt-1Fc, were added to co-cultures of LGCs and HUVECs separated by a micropore membrane. Endothelial permeability to labeled bovine serum albumin was measured and the expression of the endothelial cell-specific adhesion protein claudin 5 was investigated using immunocytochemistry and western blotting. RESULTS: The addition of hCG increased HUVEC permeability in the presence of LGCs (P < 0.05). hCG increased VEGF concentrations in both chambers of the co-culture system (P < 0.05). The increased permeability in the presence of LGCs and hCG was inhibited when VEGF was blocked by Flt-1Fc (P < 0.05). Endothelial membrane claudin 5 protein was reduced in the presence of hCG and LGCs, as measured by immunocytochemistry (P < 0.05) and western blotting (P < 0.05) and this reduction was inhibited by Flt-1Fc. hCG had no direct effects on endothelial cell claudin 5. CONCLUSIONS: For OHSS, this novel paradigm suggests that hCG can increase endothelial permeability by up-regulating VEGF in LGCs which causes reduction in endothelial claudin 5 expression.


Assuntos
Permeabilidade Capilar/efeitos dos fármacos , Gonadotropina Coriônica/farmacologia , Endotélio/efeitos dos fármacos , Proteínas de Membrana/metabolismo , Síndrome de Hiperestimulação Ovariana/metabolismo , Membrana Celular/metabolismo , Células Cultivadas , Claudina-5 , Técnicas de Cocultura , Regulação para Baixo , Endotélio/metabolismo , Feminino , Humanos , Proteínas de Membrana/análise , Proteínas de Membrana/genética , Proteínas Recombinantes de Fusão , Fator A de Crescimento do Endotélio Vascular/antagonistas & inibidores , Receptor 1 de Fatores de Crescimento do Endotélio Vascular
2.
Gynecol Oncol ; 109(3): 418-25, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18395779

RESUMO

OBJECTIVE: This study examined the potential role of Angiotensin II for the regulation of angiogenesis associated genes in receptor positive and negative human breast cancer. METHODS: Expression of different Renin-Angiotensin system (RAS) components in human breast cancer tissue was investigated using immunofluorescence, and in a receptor positive (MCF-7) and receptor negative (MDA-MB 468) breast cancer cell line by performing immunocytochemistry and RT-PCR. Both cell lines were stimulated with Angiotensin II and Angiotensin II receptor type 1 (At(1)R) blocker Candesartan, and gene expression of vascular endothelial growth factor (VEGF), Angiopoietin 1 and 2 (Ang-1 and Ang-2), tissue inhibitor of matrix metalloproteinases 1 (TIMP-1), and hypoxia inducible transcription factor 2alpha (HIF-2alpha) were quantified by TaqMan-Real-Time PCR analysis. RESULTS: RAS components, Angiotensinogen, Renin, Angiotensin I-converting enzyme (ACE), and At(1)R and At(2)R were expressed in hormone-receptor negative and positive human breast cancer tissue as well as in MDA-MB 468 and in MCF-7 human breast cancer cells. In addition, we found expression of VEGF, Ang-1, TIMP-1, and HIF-2alpha in both cell lines. However, only in receptor negative MDA-MB 468 cells, did Angiotensin II significantly increase gene expression of VEGF, HIF-2alpha, and TIMP-1. This effect was completely inhibited by Candesartan. CONCLUSION: In conclusion, it is hypothesized that Angiotensin II may be involved in regulation of tumor angiogenesis especially in receptor negative breast cancer by regulation of angiogenesis associated genes via At(1)R. These findings are the first evidence for targeting tumor angiogenesis by inhibition of At(1)R in receptor negative human breast cancer cells and may lead to new therapeutical anticancer strategies based upon inhibition of At(1)R.


Assuntos
Neoplasias da Mama/irrigação sanguínea , Sistema Renina-Angiotensina/fisiologia , Angiopoietina-1/biossíntese , Angiopoietina-1/genética , Angiopoietina-2/biossíntese , Angiopoietina-2/genética , Angiotensina II/farmacologia , Bloqueadores do Receptor Tipo 1 de Angiotensina II/farmacologia , Fatores de Transcrição Hélice-Alça-Hélice Básicos/biossíntese , Fatores de Transcrição Hélice-Alça-Hélice Básicos/genética , Benzimidazóis/farmacologia , Compostos de Bifenilo , Neoplasias da Mama/metabolismo , Linhagem Celular Tumoral , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Neovascularização Patológica/genética , Neovascularização Patológica/metabolismo , Receptor Tipo 1 de Angiotensina/biossíntese , Receptores de Estrogênio/biossíntese , Sistema Renina-Angiotensina/efeitos dos fármacos , Tetrazóis/farmacologia , Inibidor Tecidual de Metaloproteinase-1/biossíntese , Inibidor Tecidual de Metaloproteinase-1/genética , Fator A de Crescimento do Endotélio Vascular/biossíntese , Fator A de Crescimento do Endotélio Vascular/genética
3.
Reproduction ; 136(1): 125-30, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18390690

RESUMO

This study was performed in order to evaluate the role of angiotensin II in physiological angiogenesis. Human umbilical vein endothelial cells (HUVEC) were stained for angiotensin II type 1 receptor (AGTR1) immunocytochemically and for gene expression of renin-angiotensin system (RAS) components. The regulation of the angiogenesis-associated genes vascular endothelial growth factor (VEGF) and angiopoietins (ANGPT1 and ANGPT2) were studied using quantitative RT-PCR. Furthermore, we examined the effect of angiotensin II on the proliferation of HUVEC using Ki-67 as well as BrdU immunocytochemistry and investigated whether the administration of the AGTR1 blocker candesartan or the VEGF antagonist FLT1-Fc could suppress the observed angiotensin II-dependent proangiogenic effect. AGTR1 was expressed in HUVEC and the administration of angiotensin II significantly increased the gene expression of VEGF and decreased the gene expression of ANGPT1. Since the expression of ANGPT2 was not affected significantly the ratio of ANGPT1/ANGPT2 was decreased. In addition, a significantly increased endothelial cell proliferation was observed after stimulation with angiotensin II, which was suppressed by the simultaneous administration of candesartan or the VEGF antagonist FLT1-Fc. These results indicate the potential capacity of angiotensin II in influencing angiogenesis by the regulation of angiogenesis-associated genes via AGTR1. Since VEGF blockade opposed the effect of angiotensin II on cell proliferation, it is hypothesised that VEGF mediates the angiotensin II-dependent effect in concert with the changes in angiopoietin expression. This is the first report of the RAS on the regulation of angiogenesis-associated genes in physiology.


Assuntos
Células Endoteliais/citologia , Neovascularização Fisiológica , Sistema Renina-Angiotensina/fisiologia , Angiopoietina-1/genética , Angiopoietina-1/metabolismo , Angiopoietina-2/genética , Angiopoietina-2/metabolismo , Angiotensina II/metabolismo , Angiotensina II/farmacologia , Benzimidazóis/farmacologia , Compostos de Bifenilo , Proliferação de Células , Células Cultivadas , Células Endoteliais/metabolismo , Feminino , Humanos , Imuno-Histoquímica , Receptor Tipo 1 de Angiotensina/análise , Receptor Tipo 1 de Angiotensina/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos , Tetrazóis/farmacologia , Veias Umbilicais , Fator A de Crescimento do Endotélio Vascular/genética , Fator A de Crescimento do Endotélio Vascular/metabolismo , Receptor 1 de Fatores de Crescimento do Endotélio Vascular/genética , Receptor 1 de Fatores de Crescimento do Endotélio Vascular/metabolismo
4.
Mol Hum Reprod ; 13(11): 781-9, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18006538

RESUMO

Ovarian follicular and corpus luteum development, including angiogenesis, are characterized by cell-cell rearrangements that may require dynamic changes in cell-cell adhesion. The present study investigates the expression of tight junction proteins occludin and claudin 5 during follicular and luteal development in the primate ovary and after inhibition of vascular endothelial growth factor (VEGF) by VEGF trap treatment. Occludin was localized to the plasma membrane of granulosa cells. During follicular development occludin staining decreased significantly (P < 0.05) and disappeared completely by the ovulatory stage. After inhibition of VEGF, occludin staining was significantly (P < 0.05) higher in the granulosa of secondary and tertiary follicles compared with controls. Claudin 5 was exclusively localized to the theca vasculature. A significant (P < 0.05) increase in staining was detected from the pre-antral to the antral and ovulatory stage. However, dual staining with CD31 revealed that within the theca endothelium the amount of claudin 5 remained constant during follicular development. Treatment with VEGF trap throughout the follicular phase revealed a lack of claudin 5 staining in the theca interna but no difference was observed in the remaining theca externa vasculature. In the corpus luteum, claudin 5 was also localized in the vasculature. Treatment with VEGF trap in the mid-luteal phase resulted in a significant increase in staining (P < 0.05). These results led us to hypothesize that tight junctions are involved in regulation of follicular growth, antrum transition and follicular angiogenesis which is compromised by VEGF inhibition. VEGF may influence luteal vascular permeability by regulation of the endothelial specific tight junction protein claudin 5.


Assuntos
Proteínas de Membrana/metabolismo , Ovário/efeitos dos fármacos , Fator A de Crescimento do Endotélio Vascular/farmacologia , Animais , Callithrix , Feminino , Imuno-Histoquímica , Ocludina , Ovário/metabolismo , Ovulação/efeitos dos fármacos , Ovulação/metabolismo , Molécula-1 de Adesão Celular Endotelial a Plaquetas/metabolismo
6.
Artigo em Alemão | MEDLINE | ID: mdl-11227311

RESUMO

The anaesthetist would ideally like the following to be observed in a timely order in the antenatal phase: 1. early provision of information to the patient regarding epidural catheter for pain relief in labour, 2. informing the anaesthetist about relevant points in the patient history and examination findings, 3. knowledge of the contraindications to lumbar regional anaesthesia, 4. clear information as to the urgency of a caesarian section, 5. provision of aspiration prophylaxis. In the intrapartum phase it is necessary through clear communication to agree early on: 1. monitoring instructions for epidurals in the delivery room, 2. instructions for epidural top ups, 3. whether the presence of relatives in theatre in the case of a caesarian section is appropriate. In the postnatal phase anaesthetists expect to be actively involved in the resuscitation of newborns to fulfill educational requirements, to have clear decisions about responsibilities for monitoring of patients post caesarian sections and detailed information about early symptoms of possible complications of lumbar regional anaesthesia.


Assuntos
Anestesiologia , Parto Obstétrico , Obstetrícia , Adulto , Feminino , Humanos , Gravidez
7.
Cranio ; 14(2): 97-103; discussion 104-5, 1996 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-8949864

RESUMO

This study describes a hitherto unreported, functionally distinct craniomandibular muscle as observed in 25 cadaveric specimens and MRI scans of clinical patients. The muscle was consistently observed as originating from the maxillary surface of the sphenoid bone and inserting on the temporal crest (internal oblique line) of the mandible. This anatomic observation should broaden our understanding of craniomandibular function and may have clinical implications regarding retro-orbital pain.


Assuntos
Músculos Faciais/anatomia & histologia , Mandíbula/anatomia & histologia , Osso Esfenoide/anatomia & histologia , Músculo Temporal/anatomia & histologia , Terminologia como Assunto , Idoso , Idoso de 80 Anos ou mais , Classificação , Feminino , Humanos , Masculino , Mastigação/fisiologia , Pessoa de Meia-Idade , Base do Crânio/anatomia & histologia
9.
Spine (Phila Pa 1976) ; 20(23): 2484-6, 1995 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-8610241

RESUMO

STUDY DESIGN: Anatomic study of the suboccipital region, specifically the deep muscles of the suboccipital triangle, was performed in cadaveric specimens. OBJECTIVE: To observe and describe the relationship between the deep suboccipital musculature and the spinal dura. SUMMARY OF BACKGROUND DATA: A review of the literature revealed no reports describing a physical connection between suboccipital musculature and the spinal dura. METHODS: Dissections of the suboccipital region were performed in 10 embalmed and one fresh sagittally hemisected head and neck specimens. RESULTS: A connective tissue bridge between the rectus capitis posterior minor muscle and the dorsal spinal dura at the atlanto-occipital junction was observed in every specimen. The fibers of the connective tissue bridge were oriented primarily perpendicular to the dura. This arrangement of fibers appears to resist movement of the dura toward the spinal cord. CONCLUSIONS: Awareness of the physical relation between the rectus capitis posterior minor muscle and spinal dura via this connective tissue bridge should lessen the potential risk of dural damage during surgery. This connective tissue bridge may help resist dural infolding during head and neck extension.


Assuntos
Articulação Atlantoccipital/anatomia & histologia , Dura-Máter/anatomia & histologia , Músculos do Pescoço/anatomia & histologia , Adulto , Dissecação , Humanos , Masculino , Osso Occipital/anatomia & histologia
10.
Artigo em Alemão | MEDLINE | ID: mdl-7999945

RESUMO

We observed a young man with apparently septic appendicitis who finally could be diagnosed as suffering from haemolytic uraemic syndrome (HUS) when spuriously normalising platelet counts were identified as a cell counter artifact. This case stresses the fact that automatically counted abnormal thrombocyte numbers should be examined by microscopy. Therapy is empirically based on corticosteroids, plasmapheresis and fresh frozen plasma. The application of thrombocyte concentrates should be avoided because of the risk of aggravating the disease process.


Assuntos
Cuidados Críticos , Síndrome Hemolítico-Urêmica/diagnóstico , Adulto , Apendicectomia , Apendicite/diagnóstico , Apendicite/cirurgia , Colecistectomia , Diagnóstico Diferencial , Falha de Equipamento , Síndrome Hemolítico-Urêmica/sangue , Síndrome Hemolítico-Urêmica/terapia , Humanos , Masculino , Contagem de Plaquetas/instrumentação , Complicações Pós-Operatórias/sangue , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/terapia
11.
Am J Orthod Dentofacial Orthop ; 104(6): 544-55, 1993 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8249930

RESUMO

Many evaluations of soft tissue changes after orthognathic surgery have been undertaken, and many correlations of soft tissue to hard tissue movements have been established. These studies have not, however, specifically discussed the long-term stability or characteristics of the soft tissue changes. The objectives of this study were (1) to determine the long term stability of soft tissue changes 5 years after LeFort I osteotomy, (2) to determine reliable correlations, if any, of soft tissue changes to bony movements effected in surgery, and (3) to determine the predictability of soft tissue changes as an aid to orthodontic treatment planning. Cephalometric data from 25 patients who were treated with LeFort I osteotomy with or without a concurrent mandibular procedure were analyzed retrospectively. Cases were selected from the patient records of the Department of Oral Surgery of the Vrije Universiteit in Amsterdam, the Netherlands. These patients were followed up at four time points, the last being a mean of 6.1 years after surgery. Analysis of stability data revealed that most horizontal and vertical soft tissue change after LeFort I surgery occurred in the first year after surgery. Significant (> 10%) change continued to occur for subnasale, labrale inferius, upper lip protrusion, lower lip protrusion, and soft tissue convexity during the subsequent 5 years. Hard tissue to soft tissue correlations were calculated and ratios of soft tissue to hard tissue movement were determined for appropriate hard and soft tissue landmarks at four time intervals. Reliable correlations of hard tissue change at surgery to 5-year soft tissue change could be made for 10 variables, which was considerably less frequently than for 1-year soft tissue change. The relatively low reliability of long-term prediction correlations suggests that soft tissue movements may be more independent of hard tissue over time. One-year prediction values were similar to 5-year values and thus could be used for prediction purposes in orthodontic treatment planning. Most short-term hard to soft tissue correlations found in the present study were in the range of those established by previous authors. Long-term hard tissue to soft tissue correlations gave higher ratios of soft tissue movement secondary to maxillary surgery, approaching ratios of 1.0:1.0 for some variables. This finding, as well as the long-term stability data, suggest that soft tissue settling or equilibrium after surgery may take several years to complete.


Assuntos
Face/anatomia & histologia , Mandíbula/cirurgia , Retrognatismo/cirurgia , Adolescente , Adulto , Cefalometria , Queixo/anatomia & histologia , Feminino , Seguimentos , Humanos , Lábio/anatomia & histologia , Masculino , Período Pós-Operatório , Recidiva , Reprodutibilidade dos Testes , Estudos Retrospectivos
13.
Anasth Intensivther Notfallmed ; 25(5): 362-6, 1990 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-2252177

RESUMO

Based on a case report with vaginal hysterectomy, the anaesthetic implications are discussed in a patient with Shy-Drager syndrome, which is a degenerative disease in middle-aged to elderly patients, resulting in autonomic dysfunction. The syndrome is reviewed and the anaesthetic management is described. Adequate cardiovascular monitoring and maintenance of haemodynamic stability are important. The response to sympathomimetic drugs is unpredictable and may be extreme due to denervation hypersensitivity. In the postoperative period, signs of postural hypotension may be severe and require training by elevation of the upper part of the body, fluid therapy, sympathomimetics and fludrocortisone.


Assuntos
Anestesia/métodos , Histerectomia Vaginal , Síndrome de Shy-Drager/complicações , Feminino , Humanos , Pessoa de Meia-Idade , Neoplasias Uterinas/complicações , Neoplasias Uterinas/cirurgia
14.
Anasth Intensivther Notfallmed ; 20(5): 269-72, 1985 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-2867711

RESUMO

Based on a case report with surgical removal of bilateral giant phaeochromocytomas with heredofamilial affliction and suspicion of multiple endocrine neoplasia type II (MEN-II syndrome) and of malignancy, the anaesthetic implications are discussed in a patient inadvertently not prepared by antiadrenergic treatment. It is pointed out that in MEN II syndrome, a combination of phaeochromocytoma and medullary carcinoma of the thyroid, surgical removal of the phaeochromocytoma merits utmost priority before thyreoidectomy. The most important laboratory parameters in the diagnosis of MEN II syndrome are pre- and postoperative determinations of calcitonin and carcinoembryonal antigen (CEA).


Assuntos
Neoplasias das Glândulas Suprarrenais/cirurgia , Anestesia Geral , Neoplasia Endócrina Múltipla/cirurgia , Feocromocitoma/cirurgia , Neoplasias das Glândulas Suprarrenais/diagnóstico , Neoplasias das Glândulas Suprarrenais/genética , Adrenalectomia , Adulto , Cuidados Críticos , Feminino , Hemodinâmica/efeitos dos fármacos , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasia Endócrina Múltipla/diagnóstico , Feocromocitoma/diagnóstico , Feocromocitoma/genética , Pré-Medicação
15.
Anasth Intensivther Notfallmed ; 20(4): 175-8, 1985 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-2933999

RESUMO

A comparison of the haemodynamic effects of 3 anaesthetic techniques, the combinations etomidate + fentanyl (I), flunitrazepam + fentanyl (II) or midazolam + fentanyl (III), respectively was carried out in 45 patients undergoing various types of cardiac valve replacement surgery. Haemodynamics were assessed by continuously measuring the heart rate as well as the blood pressure in the systemic and pulmonary circulations whereas the cardiac output was measured intermittently. In the first 30 minutes after induction of anaesthesia, a mean arterial blood pressure drop of 10% (I), 20% (II) or 15% (III) respectively, was observed; at the same time, the rate did not change significantly. Cardiac index, however, fell significantly in all 3 groups by 33% (I) 30% (II) or 28% (III), respectively. Pulmonary pressure, wedge pressure and systemic vascular resistance rose only in groups I and III and decreased in group II (flunitrazepam + fentanyl). On the other hand, pulmonary vascular resistance as well as left ventricular work index were significantly decreased in all 3 groups. We conclude that all 3 anaesthetic techniques investigated here may be effectively applied for safe induction of anaesthesia in patients with valvular lesions of the heart. On account of the effect of the combination flunitrazepam + fentanyl on decreasing pulmonary artery pressure and wedge pressure, this technique seems to be preferable in patients with pulmonary hypertension.


Assuntos
Anestésicos/farmacologia , Benzodiazepinas/farmacologia , Etomidato/farmacologia , Fentanila/farmacologia , Flunitrazepam/farmacologia , Doenças das Valvas Cardíacas/complicações , Hemodinâmica/efeitos dos fármacos , Medicação Pré-Anestésica , Adolescente , Adulto , Idoso , Anestésicos/administração & dosagem , Benzodiazepinas/administração & dosagem , Pressão Sanguínea/efeitos dos fármacos , Débito Cardíaco/efeitos dos fármacos , Combinação de Medicamentos , Etomidato/administração & dosagem , Feminino , Fentanila/administração & dosagem , Flunitrazepam/administração & dosagem , Frequência Cardíaca/efeitos dos fármacos , Humanos , Hipertensão Pulmonar/complicações , Masculino , Midazolam , Pessoa de Meia-Idade
16.
Anasth Intensivther Notfallmed ; 20(4): 179-85, 1985 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-3907396

RESUMO

20 patients electively scheduled for operation were enrolled in the study and anaesthetized randomly with one of the two techniques etomidate + fentanyl (I) or flunitrazepam + fentanyl (II). Haemodynamics were assessed by continuously measuring blood pressure in the systemic and pulmonary circulations, as well as the heart rate, and intermittently determining the cardiac output. It could be shown that systemic arterial blood pressure, in spite of an initial drop after induction of anaesthesia, remained within an acceptable safety margin throughout the investigation period. Whereas heart rate remained almost constant in both groups, the rate-pressure product which may serve as a measure of myocardial oxygen consumption in the clinical setting, decreased considerably in both groups, although more appreciably under the influence of the anaesthetic technique flunitrazepam + fentanyl. Although the diastolic blood pressure as the most significant individual factor determining coronary blood flow was not changed appreciably in both groups, it remained at a higher level under the influence of the anaesthetic technique etomidate + fentanyl (I). We conclude that both anaesthetic regimes described here may be safely applied for the anaesthesia of patients with reduced coronary perfusion and cardio-haemodynamic reserve potential.


Assuntos
Anestesia Intravenosa/métodos , Anestésicos/farmacologia , Ponte de Artéria Coronária , Hemodinâmica/efeitos dos fármacos , Adulto , Idoso , Pressão Sanguínea/efeitos dos fármacos , Débito Cardíaco/efeitos dos fármacos , Ensaios Clínicos como Assunto , Combinação de Medicamentos , Etomidato/administração & dosagem , Etomidato/farmacologia , Feminino , Fentanila/administração & dosagem , Fentanila/farmacologia , Flunitrazepam/administração & dosagem , Flunitrazepam/farmacologia , Frequência Cardíaca/efeitos dos fármacos , Humanos , Pessoa de Meia-Idade , Distribuição Aleatória
17.
Anaesthesist ; 32(8): 392-4, 1983 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-6625147

RESUMO

Angiotensin I (A I), angiotensin II (A II) and the activity of angiotensin-converting enzyme (ACE) were measured in 15 patients undergoing cardiopulmonary bypass for mitral or aortic valve replacement. During cardiopulmonary bypass A I, A II, A I/II ratio and arteriovenous A II--difference decreased markedly, whereas the activity of ACE fell only during a small 15 min period after start of extracorporeal circulation. Possible reasons for these effects are discussed.


Assuntos
Ponte Cardiopulmonar , Doenças das Valvas Cardíacas/cirurgia , Próteses Valvulares Cardíacas , Sistema Renina-Angiotensina , Angiotensina I/sangue , Angiotensina II/sangue , Valva Aórtica/cirurgia , Feminino , Doenças das Valvas Cardíacas/sangue , Humanos , Lisina Carboxipeptidase/sangue , Masculino , Pessoa de Meia-Idade , Valva Mitral/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...